Portrai Insights
Insights on data analysis, AI, and the platform we're building at Portrai.
Latest
60 articles
Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry
Theranostics. 2019 May 18;9(12):3398–3409. Abstract Albumin is one of the most attractive nanoplatforms for targeted imaging and drug delivery due to its biocompatibility and long circulation half-li…
Portrai-
Theranostics Based on Liposome: Looking Back and Forward
Nucl Med Mol Imaging. 2019 Aug;53(4):242–246. Abstract Liposome is one of the oldest yet most successful nanomedicine platforms. Doxil®, PEGylated liposome loaded with doxorubicin (DOX), was approved…
Portrai-
Efficient renal clearance of DNA tetrahedron nanoparticles enables quantitative evaluation of kidney function.
Nano Res. 2019 Mar;12(3):637–642. Abstract DNA tetrahedron nanostructure (DTN) is one of the simplest DNA nanostructures and has been successfully applied for biosensing, imaging, and treatment of ca…
Portrai-
Europium-Diethylenetriaminepentaacetic Acid Loaded Radioluminescence Liposome Nanoplatform for Effective Radioisotope-Mediated Photodynamic Therapy
ACS Nano. 2020 Oct 27;14(10):13004–13015. Abstract Photodynamic therapy (PDT) is an effective anticancer strategy with a higher selectivity and fewer adverse effects than conventional therapies; howe…
Portrai-
Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
J Nanobiotechnology. 2020 Sep 3;18(1):122. Abstract Radiotherapy is an essential step during the treatment of glioblastoma multiforme (GBM), one of the most lethal malignancies. The survival in patie…
Portrai-
Visual interpretation of [18F]Florbetaben PET supported by deep learning-based estimation of amyloid burden
Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1116–1123. Abstract Purpose: Amyloid PET which has been widely used for noninvasive assessment of cortical amyloid burden is visually interpreted in the cli…
Portrai-
Translating amyloid PET of different radiotracers by a deep generative model for interchangeability
Neuroimage. 2021,19:117890. Abstract It is challenging to compare amyloid PET images obtained with different radiotracers. Here, we introduce a new approach to improve the interchangeability of amylo…
Portrai-
Refining diagnosis of Parkinson’s disease with deep learning-based interpretation of dopamine transporter imaging
Neuroimage Clin. 2017 Sep 10;16:586–594. Abstract Dopaminergic degeneration is a pathologic hallmark of Parkinson’s disease (PD), which can be assessed by dopamine transporter imaging such as FP-CIT …
Portrai-
Generation of structural MR images from amyloid PET: Application to MR-less quantification
J Nucl Med. 2018 Jul;59(7):1111–1117. Abstract Structural MR images concomitantly acquired with PET images can provide crucial anatomic information for precise quantitative analysis. However, in the …
Portrai-WRITTEN BY
Portrai's Authors
Capturing and compounding Portrai's insights.
Daeseung Lee
CEO
Physician-scientist who left clinical practice to bring spatial biology into oncology drug discovery
Hongyoon Choi
CTO
Builds the algorithms that turn spatial transcriptomics into actionable target intelligence
Hyung-Jun Im
CSO
Nuclear medicine specialist linking imaging biomarkers to next-generation radiopharmaceuticals
Kwonjoong Na
CMO
Translates platform insights into IND-enabling decisions across oncology programs
Portrai
Official posts from the Portrai team, decoding disease with spatial intelligence